title: Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users.
authors.forename: A C
authors.initials: AC
authors.lastname: Parrott
authors.forename: T
authors.initials: T
authors.lastname: Buchanan
authors.forename: T M
authors.initials: TM
authors.lastname: Heffernan
authors.forename: A
authors.initials: A
authors.lastname: Scholey
authors.forename: J
authors.initials: J
authors.lastname: Ling
authors.forename: J
authors.initials: J
authors.lastname: Rodgers
mesh_terms: D001921:Brain / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D006213:Hallucinogens / Q000009:adverse effects*; D006801:Humans; D013287:Illicit Drugs / Q000009:adverse effects*; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000009:adverse effects*; D010302:Parkinson Disease, Secondary / Q000209:etiology* / Q000378:metabolism; D011596:Psychomotor Disorders / Q000139:chemically induced*
chemical_list: D006213:Hallucinogens; D013287:Illicit Drugs; D018817:N-Methyl-3,4-methylenedioxyamphetamine; D004298:Dopamine